Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electroencephalogram-based Objective Assessment of Surgical Expertise during Microvascular Anastomosis Training.

Neurologia medico-chirurgica·2026
Same author

How Often Is Enough? Training Frequency Required to Maintain Microsurgical Anastomosis Skills: A Longitudinal Analysis of Self-Practice Records.

Neurosurgery practice·2026
Same author

Whole-Brain Dynamic Causal Tractography Atlas of Auditory and Visual Speech Networks Derived From Intracranial Neurophysiologic Data.

Neurology·2025
Same author

Whole-Brain Millisecond-Scale Effective Connectivity Atlas of Auditory and Visual Naming.

bioRxiv : the preprint server for biology·2025
Same author

Neuromodulation for Epilepsy.

Neurologia medico-chirurgica·2025
Same author

Changes in phosphoethanolamine during the postpartum period and its association with depression.

Fukushima journal of medical science·2025

Related Experiment Video

Updated: Jun 2, 2026

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

[Practical Guide to Antiseizure Medication Management].

Aya Kanno1

  • 1Department of Neurosurgery, Sapporo Medical University.

No Shinkei Geka. Neurological Surgery
|June 1, 2026
PubMed
Summary
This summary is machine-generated.

Perioperative seizure management in neurosurgery should be individualized. Antiseizure medications (ASMs) are recommended for patients with prior seizures or selected high-risk conditions, not routinely for seizure-naïve individuals.

Related Experiment Videos

Last Updated: Jun 2, 2026

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

Area of Science:

  • Neurosurgery
  • Neurology
  • Pharmacology

Background:

  • Perioperative seizure management is crucial in neurosurgical care.
  • Historically, prophylactic antiseizure medications (ASMs) were common, but evidence now guides selective use.
  • Current guidelines favor individualized, short-term ASM prophylaxis based on seizure risk.

Purpose of the Study:

  • To review evidence-based strategies for perioperative seizure prophylaxis in neurosurgical conditions.
  • To examine the properties of newer ASMs used in neurosurgery.
  • To discuss the role of long-term video electroencephalographic monitoring (VEEG) in neurosurgical patients.

Main Methods:

  • Literature review of evidence-based strategies for perioperative seizure prophylaxis.
  • Pharmacological review of newer ASMs (levetiracetam, lacosamide, brivaracetam, perampanel).
  • Discussion of clinical applications of VEEG.

Main Results:

  • Prophylactic ASMs are not routinely recommended for seizure-naïve neurosurgical patients.
  • ASM use should be individualized, short-term, and risk-based for specific high-risk conditions.
  • Newer ASMs offer practical advantages in perioperative settings.
  • VEEG is valuable for epilepsy surgery evaluation, nonconvulsive seizures, and differential diagnosis.

Conclusions:

  • Individualized, risk-based ASM management is essential for perioperative seizure control.
  • Judicious use of ASMs and VEEG optimizes neurological care in neurosurgical patients.
  • Short-term ASM prophylaxis is preferred to avoid long-term exposure in selected cases.